306 related articles for article (PubMed ID: 27340557)
1. Cenderitide: structural requirements for the creation of a novel dual particulate guanylyl cyclase receptor agonist with renal-enhancing in vivo and ex vivo actions.
Lee CY; Huntley BK; McCormick DJ; Ichiki T; Sangaralingham SJ; Lisy O; Burnett JC
Eur Heart J Cardiovasc Pharmacother; 2016 Apr; 2(2):98-105. PubMed ID: 27340557
[TBL] [Abstract][Full Text] [Related]
2. Natriuretic peptide based therapeutics for heart failure: Cenderitide: A novel first-in-class designer natriuretic peptide.
Ichiki T; Dzhoyashvili N; Burnett JC
Int J Cardiol; 2019 Apr; 281():166-171. PubMed ID: 29941213
[TBL] [Abstract][Full Text] [Related]
3. A Human Study to Evaluate Safety, Tolerability, and Cyclic GMP Activating Properties of Cenderitide in Subjects With Stable Chronic Heart Failure.
Kawakami R; Lee CYW; Scott C; Bailey KR; Schirger JA; Chen HH; Benike SL; Cannone V; Martin FL; Sangaralingham SJ; Ichiki T; Burnett JC
Clin Pharmacol Ther; 2018 Sep; 104(3):546-552. PubMed ID: 29226471
[TBL] [Abstract][Full Text] [Related]
4. C53: A novel particulate guanylyl cyclase B receptor activator that has sustained activity in vivo with anti-fibrotic actions in human cardiac and renal fibroblasts.
Chen Y; Zheng Y; Iyer SR; Harders GE; Pan S; Chen HH; Ichiki T; Burnett JC; Sangaralingham SJ
J Mol Cell Cardiol; 2019 May; 130():140-150. PubMed ID: 30954448
[TBL] [Abstract][Full Text] [Related]
5. CRRL269: a novel designer and renal-enhancing pGC-A peptide activator.
Chen Y; Harty GJ; Huntley BK; Iyer SR; Heublein DM; Harders GE; Meems L; Pan S; Sangaralingham SJ; Ichiki T; Burnett JC
Am J Physiol Regul Integr Comp Physiol; 2018 Mar; 314(3):R407-R414. PubMed ID: 29187381
[TBL] [Abstract][Full Text] [Related]
6. Presence of dendroaspis natriuretic peptide and its binding to NPR-A receptor in rabbit kidney.
Kim SM; Kim YA; Kim SY; Kim SH; Cho KW; Kim SZ
Regul Pept; 2011 Feb; 167(1):42-9. PubMed ID: 21130122
[TBL] [Abstract][Full Text] [Related]
7. C-type natriuretic peptide as a podocyte hormone and modulation of its cGMP production by glucose and mechanical stress.
Lewko B; Endlich N; Kriz W; Stepinski J; Endlich K
Kidney Int; 2004 Sep; 66(3):1001-8. PubMed ID: 15327393
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and actions of a novel chimeric natriuretic peptide: CD-NP.
Lisy O; Huntley BK; McCormick DJ; Kurlansky PA; Burnett JC
J Am Coll Cardiol; 2008 Jul; 52(1):60-8. PubMed ID: 18582636
[TBL] [Abstract][Full Text] [Related]
9. C-type natriuretic peptide-induced relaxation through cGMP-dependent protein kinase and SERCA activation is impaired in two kidney-one clip rat aorta.
Pernomian L; do Prado AF; Silva BR; de Paula TD; Grando MD; Bendhack LM
Life Sci; 2021 May; 272():119223. PubMed ID: 33610574
[TBL] [Abstract][Full Text] [Related]
10. CRRL269.
Chen Y; Harty GJ; Zheng Y; Iyer SR; Sugihara S; Sangaralingham SJ; Ichiki T; Grande JP; Lee HC; Wang X; Burnett JC
Circ Res; 2019 May; 124(10):1462-1472. PubMed ID: 30929579
[TBL] [Abstract][Full Text] [Related]
11. Novel bifunctional natriuretic peptides as potential therapeutics.
Dickey DM; Burnett JC; Potter LR
J Biol Chem; 2008 Dec; 283(50):35003-9. PubMed ID: 18940797
[TBL] [Abstract][Full Text] [Related]
12. C-type natriuretic peptide regulation of guanosine-3',5'-cyclic monophosphate production in human endothelial cells.
Rautureau Y; Gowers I; Wheeler-Jones CP; Baxter GF
Auton Autacoid Pharmacol; 2010 Jul; 30(3):185-92. PubMed ID: 20085572
[TBL] [Abstract][Full Text] [Related]
13. Dendroaspis natriuretic peptide and its functions in pig ovarian granulosa cells.
Piao FL; Park SH; Han JH; Cao C; Kim SZ; Kim SH
Regul Pept; 2004 May; 118(3):193-8. PubMed ID: 15003836
[TBL] [Abstract][Full Text] [Related]
14. Dendroaspis natriuretic peptide and the designer natriuretic peptide, CD-NP, are resistant to proteolytic inactivation.
Dickey DM; Potter LR
J Mol Cell Cardiol; 2011 Jul; 51(1):67-71. PubMed ID: 21459096
[TBL] [Abstract][Full Text] [Related]
15. Natriuretic peptide receptors and neutral endopeptidase in mediating the renal actions of a new therapeutic synthetic natriuretic peptide dendroaspis natriuretic peptide.
Chen HH; Lainchbury JG; Burnett JC
J Am Coll Cardiol; 2002 Sep; 40(6):1186-91. PubMed ID: 12354448
[TBL] [Abstract][Full Text] [Related]
16. Pro-Atrial Natriuretic Peptide: A Novel Guanylyl Cyclase-A Receptor Activator That Goes Beyond Atrial and B-Type Natriuretic Peptides.
Ichiki T; Huntley BK; Sangaralingham SJ; Burnett JC
JACC Heart Fail; 2015 Sep; 3(9):715-23. PubMed ID: 26362447
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic actions of a new synthetic vasoactive and natriuretic peptide, dendroaspis natriuretic peptide, in experimental severe congestive heart failure.
Lisy O; Lainchbury JG; Leskinen H; Burnett JC
Hypertension; 2001 Apr; 37(4):1089-94. PubMed ID: 11304508
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamics of a novel designer natriuretic peptide, CD-NP, in a first-in-human clinical trial in healthy subjects.
Lee CY; Chen HH; Lisy O; Swan S; Cannon C; Lieu HD; Burnett JC
J Clin Pharmacol; 2009 Jun; 49(6):668-73. PubMed ID: 19395584
[TBL] [Abstract][Full Text] [Related]
19. Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: functional cardiorenal responses to receptor antagonism.
Borgeson DD; Stevens TL; Heublein DM; Matsuda Y; Burnett JC
Clin Sci (Lond); 1998 Aug; 95(2):195-202. PubMed ID: 9680502
[TBL] [Abstract][Full Text] [Related]
20. Particulate Guanylyl Cyclase A/cGMP Signaling Pathway in the Kidney: Physiologic and Therapeutic Indications.
Chen Y; Burnett JC
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29584705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
